Daily6 小时
Roflumilast Cream Safe and Effective in Treatment of Atopic Dermatitis: JAMA
According to the recent study published in the Journal of American Medical Association, a new topical treatment for atopic dermatitis (AD) has been shown as a safe, effective, and ...
Arcutis : ZORYVE Cream 0.15% Improves Atopic Dermatitis Across Skin Types In Phase 3 Trials
(RTTNews) - Arcutis Biotherapeutics Inc.'s (ARQT) ZORYVE cream 0.15% provided consistent and meaningful improvements in signs and symptoms of atopic dermatitis in individuals regardless of race, ...
New Data Shows ZORYVE® (Roflumilast) Cream 0.15% Provided Consistent Improvement of Atopic ...
ZORYVE demonstrated consistent efficacy in disease clearance and reduction in itch for individuals with atopic dermatitis (AD) regardless of ...
FDA确定新型银屑病治疗药物审查日期
WESTLAKE VILLAGE, Calif. - 美国食品和药物管理局（FDA）已接受Arcutis Biotherapeutics, Inc.（NASDAQ:ARQT）提交的ZORYVE（roflumilast）泡沫剂补充新药申请（sNDA），该药物用于治疗头皮和身体银屑病。FDA已将处方药用户费法案（PDUFA）目标行动日期定为2025年5月22日。 Arcutis是一家处于商业化阶段的生 ...
ZORYVE乳膏在特应性皮炎治疗中显示前景
在其他近期新闻中，Arcutis Biotherapeutics报告2024年第二季度业绩强劲，净收入达到30.9百万美元，较第一季度净产品收入增长43%。这一增长主要由其皮肤病产品（包括Zoryve乳膏和泡沫）的处方量显著增长推动。Mizuho Securities和TD ...
Frontiers2 天
Frontiers in Cell and Developmental Biology
Impact and progress Frontiers' impact Progress Report 2022 All progress reports ...
verywellhealth6 天
The 11 Body Organ Systems: Anatomy and Function
University of Rochester Medical Center. Anatomy of the respiratory system. MedlinePlus. Alkalosis. National Library of Medicine. Physiology, Integument. Endocrine Society. Your health and hormones.
Medscape6 天
Roflumilast Cream 0.15% Improves Atopic Dermatitis Symptoms in Phase 3 Studies
Roflumilast cream 0.15% was well tolerated and significantly improved symptoms in adults and children with mild to moderate atopic dermatitis (AD) in two phase 3 trials. The two phase 3 randomized ...